Return On Equity ratio Analysis of Corvus Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY ROE
Period Ending - Dec-23
Very Poor ROE
-78.05
Period Ending - Dec-22
Very Poor ROE
-73.61
Growth
-6.03 %
Trailing Twelve Months ROE
Period Ending - Dec-23
Very Poor ROE
-57.89
Most recent Quarter ROE
Period Ending - Mar-24
Very Poor ROE
-17.09
ROE Analysis of Corvus Pharmaceuticals Inc
| ROE Ratio of Corvus Pharmaceuticals Inc with value of -57.89 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in trailing twelve months. |
| ROE Ratio of Corvus Pharmaceuticals Inc with value of -17.09 means is not able to effectively utilize its Shareholders Fund in order to generate a profit in latest Quarter ending on Mar-24. |
| ROE Ratio of CRVS has fallen by -6.03 % Compared to previous Financial Year. |
| ROE Ratio with value of -8.31 was highest in Year Dec-20 in last Five Years. |
| ROE Ratio of CRVS trending down for at least three Years. |
| Latest ROE Ratio with value of -78.05 is lower than Average ROE of -54.02 in last five years. |
| ROE of Corvus Pharmaceuticals Inc is negative because of poor net profit in last Financial Year , last Quarter and also in last twelve Months. |
Other ROE Related Info of CRVS that may interest you.
Corvus Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| CRVS | 2.04 | 2.12 | 3.77 % | Biotechnology |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..
ROE Related Ratios
| ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical Return On Equity of Corvus Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| ROE | -78.05 | -73.61 | -44.50 | -8.31 | -65.63 | -42.54 | -65.61 |
| Change | -6.03 % | -65.40 % | -435.59 % | 87.34 % | -54.28 % | 35.16 % | -139.55 % |
FY Chart of Return On Equity of Corvus Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)